The adaptor complex 3 (AP-3) targets membrane proteins from endosomes to lysosomes, lysosome-related organelles and synaptic vesicles. Phosphatidylinositol-4-kinase type II ␣ (PI4KII␣) is one of several proteins possessing catalytic domains that regulate AP-3-dependent sorting. Here we present evidence that PI4KII␣ uniquely behaves both as a membrane protein cargo as well as an enzymatic regulator of adaptor function. In fact, AP-3 and PI4KII␣ form a complex that requires a dileucine-sorting motif present in PI4KII␣. Mutagenesis of either the PI4KII␣-sorting motif or its kinase-active site indicates that both are necessary to interact with AP-3 and properly localize PI4KII␣ to LAMP-1-positive endosomes. Similarly, both the kinase activity and the sorting signal present in PI4KII␣ are necessary to rescue endosomal PI4KII␣ siRNA-induced mutant phenotypes. We propose a mechanism whereby adaptors use canonical sorting motifs to selectively recruit a regulatory enzymatic activity to restricted membrane domains.
INTRODUCTION
Organelles exchange components via vesicle carriers whose composition is defined by cytosolic coats. Among these coats, four heterotetrameric adaptor complexes (AP-1 to AP-4) act as scaffolds recruiting enzymatic and nonenzymatic machineries necessary for the generation of vesicles of unique composition (Bonifacino and Traub, 2003; Bonifacino and Glick, 2004; Robinson, 2004) . For example, the adaptor complex AP-3 functions to produce vesicles that traffic selected membrane proteins from endosomes to lysosomes, lysosome-related organelles, or synaptic vesicles (Di Pietro and Dell'Angelica, 2005; Danglot and Galli, 2007; NewellLitwa et al., 2007) . It is generally believed that membrane proteins packed into vesicles (cargoes) and enzymes required for vesicle formation (e.g., the GTPase ARF1) are separate molecular entities that play distinct roles in vesicle biogenesis. However, adaptors bring cargoes and these enzymatic regulators together at the time of vesicle generation.
Adaptor function can be deconstructed in at least two steps. First, adaptors must be recruited to restricted membrane domains in specific organelles. Second, once on membranes, adaptors must then recognize and concentrate membrane proteins containing sorting determinants such as tyrosine or dileucine-based sorting motifs (Bonifacino and Glick, 2004) . Both processes are tightly regulated and coordinated by proteins possessing catalytic activities. Among those, GTPases of the ARF family and lipid-modifying enzymes regulate adaptor recruitment to membranes and can influence adaptor interaction with cargo (Bonifacino and Glick, 2004; De Matteis and Godi, 2004; Honing et al., 2005; Di Paolo and De Camilli, 2006) . As an example, PtdIns(4,5)P 2 at the plasma membrane and PtdIns(4)P at the trans-Golgi network play crucial roles for the selective recruitment of AP-2 and AP-1, respectively (Godi et al., 1999; Krauss et al., 2003; Wang et al., 2003; Di Paolo et al., 2004; Bairstow et al., 2006; Nakano-Kobayashi et al., 2007) . In these examples, GTP-bound forms of ARF GTPases regulate the activities of either phosphatidylinositol 4-kinase type III␤ present in the Golgi apparatus where it generates PtdIns(4)P (Godi et al., 1999) or phosphatidylinositol 5-kinase type I␥, which catalyzes PtdIns(4,5)P 2 production at the plasma membrane (Godi et al., 1999; Krauss et al., 2003; Di Paolo et al., 2004; Bairstow et al., 2006; Nakano-Kobayashi et al., 2007) .
The functional integration of the enzymatic activity of GTPases and lipid kinases occurs because adaptors provide a scaffold to bind PI lipids, GTPases, and lipid kinases as well as membrane proteins bearing sorting signals. Binding of this diverse group of molecules to adaptors modifies the function of adaptors themselves and/or the activity of lipid kinases. For example, PI lipids regulate the affinity of adaptors for tyrosine-based sorting motifs (Honing et al., 2005) , whereas the interaction of adaptors and lipid kinases increases the enzymatic activity of the latter (Krauss et al., 2006) . In contrast with many regulatory enzymes, cargoes are membrane-bound proteins. Moreover, the function performed by cargoes and regulatory kinases are separated to distinct molecules recruited to adaptors. Here we present a new paradigm in which a lipid kinase, phosphatidylinositol 4-kinase type II␣ (PI4KII␣), associated with membranes via palmitoylation (Barylko et al., 2001) , behaves as both a cargo and enzymatic regulator of AP-3. PI4KII␣ contains a kinase domain and a dileucine-sorting motif. This dileucine-sorting motif is identical to the motif found in the AP-3 cargo tyrosinase (Honing et al., 1998; Blagoveshchenskaya et al., 1999; Theos et al., 2005) . We demonstrate that both the kinase domain and the sorting motif are required to facilitate the function of the adaptor complex AP-3, indicating that PI4KII␣ behaves both as a membrane protein cargo as well as an enzymatic regulator of AP-3 function. Our results indicate that direct recruitment of enzymatic regulators of adaptor function, in this case PI4KII␣, could operate in a positive feedback mechanism for further adaptor recruitment.
MATERIALS AND METHODS

Antibodies and Reagents
The following antibodies were used: early endosome antigen 1 (EEA1), antisyntaxin 8, anti-Vti1b, and clathrin heavy chain, (BD Biosciences, Franklin Lakes, NJ); anti-transferrin receptor (H68.4; Zymed Laboratories, South San Francisco, CA); and anti-hemagglutinin (HA; 12CA5; Roche Molecular Biochemicals, Indianapolis, IN). Anti-clathrin heavy-chain mouse mAb (X22) was from Calbiochem (La Jolla, CA). Anti-GFP mAb 3E6 was from Molecular Probes (Eugene, OR). Anti-SV2 (10H4), anti-␦ (SA4), and anti-LAMP-1 (1DCB and H4A3) were from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA). anti-3 and -␤3 AP-3 polyclonal antibodies have already been described (Salem et al., 1998; Faundez and Kelly, 2000; Salazar et al., 2004) . KF4 mAb against AP-3 ␦ was a gift from Andrew Peden (Department of Clinical Biochemistry, University of Cambridge, London, England). Mouse anti-VAMP-7 (Advani et al., 1999) and affinity-purified polyclonal antibodies against phosphatidylinositol-4-kinase type II␣ were reported previously (Guo et al., 2003) .
Cell Culture
PC12 cells and stably transfected PC12 ZnT3 clone 4 cell lines were cultured as described previously (Salazar et al., 2004) . HEK293T cells were maintained in DMEM ϩ 10% FBS ϩ 100 U/ml penicillin and 100 g/ml streptomycin (Mediatech, Herndon, VA).
Plasmids and Transfections
HA-and green fluorescent protein (GFP)-tagged human wild-type (WT) and kinase inactive PI4KII type II␣ constructs were gifts from Tamas Balla (Section on Molecular Signal Transduction, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; Balla et al., 2002) . GST-tagged rat PI4KII␣ was a gift from Pietro de Camilli (Department of Cell Biology, Yale University, New Haven, CT; Guo et al., 2003) . All mutants were created by QuickChange mutagenesis kit (Stratagene, La Jolla, CA) except the rat L60A L61A mutant created by synthesizing (IDT Technologies, Coralville, IA) an oligo corresponding to PI4KII␣ base pairs 79 -193 with the sequence 5ЈCACTTTCCACAAGTACCAGGAGGAGCAGTAGCAGCAGCAG-GATCAGGACCATCACCACCATGTTCTCCAGGACATGATCGTGAACGAC-AACCAGCAGCAGATCGAGCC-3Ј. The reverse complement oligo was also synthesized, and the two oligos were annealed and ligated into the SacI and SmaI sites in rat PI4KII. WT and L60A L61A mutant rat PI4KII␣ was then subcloned into pEGFP-C2 using the EcoRI and SalI restriction sites. PC12 cells were transfected as described previously (Salazar et al., 2005) . HEK293T cells were seeded in six-well plates and transfected with 200 ng of plasmid DNA in 1 ml of OPTI-MEM media (Invitrogen, Carlsbad, CA) . After 4 h the medium was replaced with 2 ml DMEM ϩ 10% FBS, and cells were assayed the following day.
RNA Interference
Double-stranded RNA oligos corresponding to nucleotides 888 -908 of human PI4K type II␣ (NM_018425; Wang et al., 2003) and siCONTROL nontargeting small interfering RNA (siRNA) 2 (5Ј-UAAGGCUAUGAAGAGAUAC-3Ј) control siRNA oligos were obtained from Dharmacon (Lafayette, CO). HEK293T cells, 5 ϫ 10 5 , were seeded in six-well plates and transfected on day 2 with 100 nmol of siRNA in 1 ml OPTI-MEM. After 4 h, 1 ml of DMEM ϩ 10% FBS was added to each well. On day 3 the medium was replaced with 2 ml DMEM ϩ 10% FBS. On day 4 the cells were trypsinized with 1 ml of 0.05% trypsin in PBS for 1 min and then 1 ml of DMEM ϩ 10% FBS was added to each well. After 2 h the cells were washed and transfected again with siRNA as described above. On day 5 the media was replaced as above, and cells were either left alone or passaged in order to seed coverslips. On day 6 the cells were either left alone or transfected with plasmid DNA as described above, and cells were processed for immunoblot and immunofluorescence on day 7.
Dithiobis(succinimidylpropionate) Cross-linking of Intact Cells and Immunoprecipitation of Cross-linked Protein Complexes
To assess low-affinity interactions between AP-3 and cargoes, we performed cross-linking in whole cells with DSP [dithiobis(succinimidylpropionate)]. Cross-linking by DSP can be reverted by reducing agents allowing the identification of individual proteins in SDS-PAGE. Cross-linked complexes were immunoprecipitated with AP-3 antibodies, cross-linking was reversed by reducing agents and precipitated proteins were analyzed by SDS-PAGE and immunoblot. Briefly, 5 ϫ 10 5 cells were plated in six-well plates and on the day of confluence were placed on ice, rinsed twice with PBS, and incubated with 1 mM DSP (Pierce, Rockford, IL) or vehicle diluted in PBS for 2 h on ice. Tris, pH 7.4, was added to 25 mM and incubated for 15 min to quench the DSP reaction. The cells were then rinsed twice with PBS and lysed in buffer A (150 mM NaCl, 10 mM HEPES, 1 mM EGTA, and 0.1 mM MgCl 2 , pH 7.4) ϩ 0.5% TX-100 by incubation for 30 min on ice. The cells were then scraped from the dish, and cell homogenates were centrifuged at 16,100 ϫ g for 10 min. The supernatant was recovered, diluted to 1 mg/ml in 0.5 ml of buffer A ϩ 0.5% TX-100, applied to Dynal magnetic beads (Invitrogen) coated with antibody, and incubated overnight at 4°C. The beads were then washed 4 times with buffer A ϩ 0.1% TX-100, eluted by 5 min of incubation at 75°C with SDS-PAGE sample buffer, and immunoprecipitated material was analyzed by SDS-PAGE and immunoblot.
To quantify the extent of PI4KII␣ association with AP-3 in the presence of DSP, HA-tagged versions of WT PI4KII␣ were used as a reference point to which compare mutant PI4KII␣ versions. The percent of association was estimated as [(AP-3-bound mutant PI4KII␣-HA/Mutant PI4KII␣-HA expression) ϫ (AP-3-bound PI4KII␣-HA/PI4KII␣-HA expression) Ϫ1 ] ϫ 100. Membrane and cytosol fractions were prepared after cross-linking as described above. HEK293 cells were washed in PBS and homogenized in buffer A containing Complete antiprotease cocktail, by 18 passages in a cell cracker. Homogenate was sedimented at 27,000 ϫ g for 40 min to generate a P1 membrane fraction and a S1 supernatant. Cytosol-free of membranes was obtained by centrifugation of S1 at 210,000 ϫ g for 30 min in a Beckman Coulter TLA120.2 rotor. Membrane fractions and cytosol were dissolved in buffer A 0.5% Triton X-100 (TX-100) during 30 min on ice. Cell fractions were clarified by centrifugation, and Triton-soluble supernatants were immunoprecipitated as described above.
AP-3 Immunoaffinity Chromatography and In Vitro Binding Assay
Magnetic beads coated with anti AP-3 ␦ antibodies or control beads, either coated with an irrelevant antibody (SV2) or lacking antibodies, were preincubated overnight with 500 g of rat brain cytosol diluted in buffer A ϩ 3% BSA ϩ 0.1% TX-100, washed five times with the same buffer, and then incubated with 125 nM glutathione S-transferase (GST) or GST-PI4KII␣ diluted in the same buffer for 2 h at 4°C. The beads were then washed four times with the same buffer and then once with buffer A ϩ 0.1% TX-100. The beads were eluted by incubating with SDS-PAGE sample buffer at 75°C for 5 min, and bound material was analyzed by SDS-PAGE and immunoblot. The sequence of the peptide corresponding to the epitope recognized by the anti-␦ SA4 mAb was AQQVDIVTEEMPENALPSDEDDKDPNDPYRA corresponding to the amino acids 680 -710 of human ␦ adaptin (AAD03777; GI:1923266).
Microscopy
Immunofluorescence was performed as described previously (Salazar et al., 2004) . All cells were seeded on coverslips coated with Matrigel (BD Biosciences). Images were acquired either by confocal microscopy (detailed in Salazar et al., 2004) or with a scientific-grade cooled charge-coupled device (Cool-Snap HQ with ORCA-ER chip) on a multiwavelength, wide-field, threedimensional microscopy system (Intelligent Imaging Innovations, Denver, CO), based on a 200M inverted microscope using a 63ϫ NA 1.4 lens (Carl Zeiss, Thornwood, NY). Immunofluorescent samples were imaged at room temperature using a Sedat filter set (Chroma Technology, Rockingham, VT), in successive 0.20-m focal planes. Out-of-focus light was removed with a constrained iterative deconvolution algorithm (Swedlow et al., 1997) . Images were processed and analyzed using Metamorph software Version 3.0 (Universal Imaging, West Chester, PA). All images were thresholded to similar levels. Fluorescent signal colocalization or overlapping was determined as follows. For each cell, an optical section obtained through the nuclear equator was analyzed. Pixels containing both fluorescent signals were considered colocalized or overlapped. This value was expressed as a percent of the total number of pixels positive for just one fluorochrome. Endosomal colocalization was quantified by creating a region of interest surrounding a single enlarged endosome, and only the pixels included in that region of interest were measured for colocalization. Penetrance of siRNA phenotypes was determined by counting the number of cells displaying or not displaying a given phenotype and dividing the number of cells displaying the phenotype by the number of total cells, yielding the percentage of cells displaying the phenotype.
Statistical Analysis
All data are expressed as average Ϯ SE. Experimental conditions were compared with the one-way ANOVA followed by Student-Newman-Keuls Multiple Comparison as a post hoc test using Synergy KaleidaGraph v3.6.2 (Reading, PA).
RESULTS
PI4KII␣ Colocalizes Specifically with AP-3 and AP-3 Cargoes on the Limiting Membrane of Early Endosomes
PI4KII␣ specifically colocalizes with AP-3 and AP-3 cargoes in neuronal and nonneuronal cells (Salazar et al., 2005 (Salazar et al., , 2006 and is present in AP-3-derived microvesicles and synaptic vesicles (Guo et al., 2003; Salazar et al., 2005; Takamori et al., 2006) . The localization of PI4KII␣ to these compartments requires AP-3 (Salazar et al., 2005 (Salazar et al., , 2006 , suggesting that PI4KII␣ is targeted by interacting with AP-3. If the kinase is indeed targeted by AP-3, a prediction arising from this hypothesis is that PI4KII␣, AP-3, and other AP-3 cargo molecules should colocalize on the limiting membrane of early endosomes, a donor compartment where AP-3 vesicles are formed Peden et al., 2004) . We tested this hypothesis using high-resolution deconvolution immunofluorescence microscopy of PC12 cells transfected with constitutively active Rab5a (Rab5Q79L, Figure 1 ). Rab5Q79L causes the formation of enlarged early endosomes (Stenmark et al., 1994) that allow the visualization of presumptive sorting microdomains on their limiting membrane at the light microscopy level (Raiborg et al., 2002 (Raiborg et al., , 2006 . PC12 cells expressing GFP-Rab5Q79L were fixed and stained for PI4KII␣, AP-3, clathrin, and two well-defined AP-3 cargo molecules, ZnT3 (Salazar et al., 2004 (Salazar et al., , 2005 and VAMP-7 (Martinez- Arca et al., 2003; Salazar et al., 2006; Scheuber et al., 2006) . Approximately 50% of the PI4KII␣ on the membrane of these enlarged endosomes was found to coexist with AP-3 ( Figure   1A ) and the AP-3 cargoes ZnT3 and VAMP-7 (Figure 1 , B and C) as well as clathrin ( Figure 1F ) in discrete microdomains. The extent of colocalization between PI4KII␣ and either AP-3, ZnT3, or VAMP7-TI are in agreement with those obtained from quantification of whole cell colocalization in untransfected PC12 cells and mouse skin fibroblasts (Salazar et al., 2005 (Salazar et al., , 2006 . To test if this colocalization was specific to AP-3 and AP-3 cargoes, we stained enlarged endosomes with antibodies to the adaptor AP-1 and transferrin receptor (TrfR, Figure 1 , D and E), a transmembrane protein that traffics independently of AP-3 (Dell'Angelica et al., 1999; Janvier and Bonifacino, 2005) . We observed only minimal amounts of AP-1 on enlarged endosomes ( Figure 1G ), and a perinuclear pool of AP-1 that partially colocalized with PI4KII␣ ( Figure 1E ). Furthermore, the colocalization between PI4KII␣ and TrfR on these endosomes was 2.7-fold lower than that of PI4KII␣ and AP-3, and 3.8-fold lower than that of PI4KII␣ and ZnT3 ( Figure 1G ). These results indicate that PI4KII␣, AP-3, AP-3 cargoes, and clathrin are specifically enriched in early endosome microdomains that are mostly devoid of TrfR and AP-1.
PI4-Kinase Interacts with AP-3 In Vitro and In Vivo
The enrichment of PI4KII␣ and AP-3 in endosomal microdomains, combined with the observations that AP-3 is required to target PI4KII␣ to postendocytic compartments (Salazar et al., 2005) suggest that the kinase and AP-3 could interact. To test this hypothesis, we developed an in vitro binding assay using affinity-purified AP-3 complexes and purified recom- binant PI4KII␣. AP-3 complexes were isolated from rat brain cytosol by immunoaffinity chromatography using magnetic beads decorated with a mAb directed against the ear domain of the ␦ subunit of AP-3 ( Figure 2A , KF4, lanes 9 and 10). Beads decorated with AP-3 complexes were washed and challenged with purified GST (Figure 2A , lane 9) or GSTtagged PI4KII␣ (Figure 2A , lane 10). In contrast with GST, which failed to bind to AP-3-containing beads ( Figure 2A , lane 9), GST-PI4KII␣ specifically bound to beads carrying immobilized AP-3 complexes ( Figure 2A, lane 10) . Furthermore, GST-PI4KII␣ did not bind to beads lacking antibodies ( Figure 2A , lanes 4 and 5) or to beads coated with an irrelevant antibody directed against SV2, a multispanning membrane protein (Bajjalieh et al., 1992;  Figure 2A , lanes 6 and 7). These results were recapitulated using a different mAb whose antigenic peptide epitope in the ␦ subunit of AP-3 has been identified (anti-␦ SA4, Figure 2B , ␦). To further test the selectivity of the AP-3/PI4KII␣ interaction, we performed competition experiments using a synthetic peptide corresponding to the epitope recognized by anti-␦ SA4 mAb. Inclusion of the peptide during the AP-3 immunoprecipitation completely out-competed the interaction between the ␦ antibody and AP-3 and prevented the subsequent binding of GST-PI4KII␣ to beads ( Figure 2B , lanes 9 and 10). These in vitro data provide evidence of an interaction between AP-3 and PI4KII␣.
We hypothesized that a sorting motif in PI4KII␣ was required for the interaction between the kinase and AP-3. This hypothesis was founded on the observation that sorting motifs interact directly with AP-1 or AP-3 (Janvier et al., 2003; Doray et al., 2007) . Computational analysis of rat PI4KII␣ amino acid sequence revealed the presence of three putative dileucine motifs that conform to the canonical dileucine sorting signal {DER}XXXL{LVI}: 3 ETSPLV 8 , 56 ERQPLL 61 , and 378 EIKDLI 383 ; the latter contained in the kinase domain of PI4KII␣. We focused on putative sorting signals present outside the kinase domain. Among these, 56 ERQPLL 61 was conserved in all vertebrate PI4KII␣ isoforms. The conservation of 56 ERQPLL 61 suggests that this motif may play a central role in PI4KII␣ interaction with AP-3 and targeting. In fact, this motif is identical to the AP-3-interacting motif (ERQPLL) found in tyrosinase, a well-characterized membrane protein that depends on AP-3 for sorting (Honing et al., 1998; Blagoveshchenskaya et al., 1999; Huizing et al., 2001; Theos et al., 2005) . To test this hypothesis, we first developed a strategy to analyze adaptor-cargo interactions on membranes in vivo using whole-cell cross-linking. We chose DSP, a homobifunctional cell-permeable cross-linker with a 12-Å spacer arm that contains a disulfide bond that allows the cleavage of cross-linked products (Lomant and Fairbanks, 1976; Alloza et al., 2004; Xiang et al., 2004) . Adaptor complexes bound to cargoes were immunoprecipitated, and their molecular composition was analyzed by reducing SDS-PAGE and immunoblot. Immunoprecipitation of AP-3 from cells treated with DSP resulted in coprecipitation of PI4KII␣ ( Figure 3A, lane 8) . The complex between AP-3 and PI4KII␣ was observed even though DSP treatment decreased the immunoreactivity of the AP-3 ␦ subunit, as revealed by the decreased precipitation of AP-3 subunits ( Figure 3A , 3 and ␤3 blots, compare lanes 7 and 8). Control immunoprecipitations using beads without antibody ( Figure 3A , lanes 3 and 4) or immunoprecipitation of transferrin receptor (TrfR, Figure 3A , lanes 5 and 6) failed to coprecipitate PI4KII␣, indicating a specific interaction between PI4KII␣ and AP-3. We predicted that AP-3 cargo proteins colocalizing with AP-3 and PI4KII␣ in Rab5Q79L-enlarged endosomes (Figure 1 ) would also be found cross-linked to PI4KII␣-AP-3 complexes. In fact, PI4KII␣ was present in a complex containing AP-3 subunits, the AP-3 cargo ZnT3, and clathrin ( Figure 3B , lanes 5 and 6). Similarly, PI4KII␣-AP-3 and clathrin were immunoprecipitated as a complex from cross-linked PC12 cells using X22 clathrin antibodies (data not shown). The presence of PI4KII␣ and ZnT3 in AP-3 cross-linked complexes is selective because minimal or undetectable levels of PI4KII␣ or ZnT3, respectively, were found in cross-linked AP-1 complexes immunoprecipitated with ␥ adaptin antibodies ( Figure 3B , compare lanes 2 and 6). The efficient cross-linking of clathrin to AP-1 excludes the possibility that AP-1 and its interactors are refractory to DSP treatment. These data demonstrate that PI4KII␣ can be cross-linked and selectively coimmunoprecipitated with AP-3. Furthermore, these findings are consistent with a model in which PI4KII␣ behaves as a cargo that binds to AP-3.
PI4KII␣ binding to AP-3 could be mediated by the conserved 56 ERQPLL 61 dileucine motif in PI4KII␣. To test this prediction, we mutated the critical leucine residues (Bonifacino and Traub, 2003) in this motif to alanines and expressed WT and dileucine mutant (L60A L61A) GFP-tagged rat PI4KII␣ in HEK293 cells ( Figure 3C ) and PC12 cells (data not shown). Cells were cross-linked with DSP, and immu- Figure 2 . Purified PI4KII␣ and AP-3 interact in vitro. (A) AP-3 was purified from rat brain cytosol by immunoaffinity chromatography using a mAb (KF4) to the ␦ subunit of AP-3. The cytosol preincubated beads were washed extensively (see Material and Methods) and incubated with 125 nM purified GST-PI4KII␣ (lanes 4 -8 and 10) or 125 nM GST alone (lane 9). Bound GST-PI4KII␣ was detected by SDS-PAGE and immunoblot using antibodies to the ␤3 subunit of AP-3 and GST. GST alone fails to bind to beads coated with AP-3 (lane 9). Control immunoprecipitations using beads without antibody (lanes 4 and 5), irrelevant antibody (SV2, lanes 6 and 7), or absence of cytosol (lane 8) display only background levels of bound GST-PI4KII␣, whereas beads coated with purified AP-3 display significant GST-PI4KII␣ binding. GST and GST-PI4KII␣ inputs (lanes 1 and 2) are 15% and cytosol input is 2.5%. (B) Purification, binding of AP-3 and GST-PI4KII␣, and detection of bound GST-PI4KII␣ was performed as in A, except that the mAb used for AP-3 immunoaffinity purification was ␦ (anti-␦ SA4 monoclonal). A peptide corresponding to the epitope recognized by the ␦ antibody was used to elute bound AP-3 (lanes 9 and 10). Inclusion of the peptide during AP-3 immunoaffinity purification out-competed the interaction between the antibody and AP-3 (lanes 9 and 10). As in A, GST-PI4KII␣ failed to bind to uncoated beads (lane 4), beads coated with irrelevant antibody (lane 5, SV2), or to beads coated with ␦ antibody but lacking AP-3 (lane 6), and GST alone does not bind AP-3 (lane 7).
noprecipitations were performed using lysates from each of these cell lines. Immunoprecipitation of AP-3 coprecipitated GFP-PI4KII␣ ( Figure 3C , lane 10), whereas no detectable dileucine mutant GFP-PI4KII␣ coprecipitated with AP-3 ( Figure 3C , compare lanes 10 and 12). Similar results were obtained using WT and dileucine mutant HA-tagged PI4KII␣ (see Figure 9 ). Control immunoprecipitations using beads without antibody failed to coprecipitate all but background levels of the kinase ( Figure 3C, lanes 5-8) . These immunoprecipitations were repeated using PC12 cells and yielded similar results (data not shown). Collectively our results indicate that the 56 ERQPLL 61 motif is necessary for the PI4KII␣/AP-3 interaction in vivo.
PI4-Kinase siRNA Knockdown Selectively Redistributes AP-3 Complexes from Membranes to Cytosol
If cargo possesses catalytic activity capable of selectively regulating adaptor recruitment to membranes, then depletion of such a molecule should lead to adaptor redistribution to cytosolic compartments. To test this hypothesis, we performed siRNA-mediated PI4KII␣ knockdown in HEK293 cells ( Figure 4A , compare lanes 2 and 3, and Figure 9A , compare lanes 1 and 2). We analyzed AP-3 and -1 adaptor membrane localization both by confocal immunofluorescence microscopy ( Figure 4 , B and C) as well as subcellular fractionation of control or PI4KII␣ siRNA-treated cells (Figure 4D ). As previously reported by us in other cell types (see Figure 1 ; Salazar et al., 2005 Salazar et al., , 2006 , PI4KII␣ preferentially colocalizes with AP-3, mostly in the perinuclear area, but minimally with AP-1 complexes (data not shown and Figure  5C , f). Consistent with these findings, PI4KII␣ down-regulation selectively affected AP-3 but not AP-1 adaptor subcellular localization (Figure 4 , compare B and C). Reduced PI4KII␣ levels induced a redistribution of AP-3 from a perinuclear cap into a disperse pattern throughout the cytoplasm. To confirm these observations, we performed subcellular fractionation of HEK293 cells either treated with control or PI4KII␣ siRNA oligonucleotides ( Figure 4D ). siRNA-treated cells were incubated in the absence ( Figure  4D , odd lanes) or presence of DSP ( Figure 4D , even lanes), as previously described (Figure 3) , homogenized, and fractionated into cytosol and membrane fractions. Detergent-solubilized subcellular fractions were immunoprecipitated with antibodies against AP-3 ␦ or AP-1 ␥ adaptins. Cytosolic fractions were mostly devoid of contaminant membrane proteins as determined by the absence of PI4KII␣ ( Figure  4D , compare lanes 9 and 11) and TrfR (not shown). Antibodies against AP-3 ␦ adaptin effectively precipitated PI4KII␣ and associated clathrin from membranes isolated from control siRNA and cross-linker-treated cells ( Figure  4D , compare lanes 3 and 4, top panels). However, under identical conditions, AP-1 ␥ adaptin antibodies failed to precipitate detectable PI4KII␣. Despite this, clathrin coprecipitating with AP-1 was readily detectable ( Figure 4D , compare lanes 3 and 4, bottom panels). PI4KII␣ down-regulation ( Figure 4D , lanes 5-8) drastically decreased the amount of AP-3 and associated clathrin present in cross-linked membrane fractions ( Figure 4D , compare lanes 4 and 8, top panels). We observed a similar reduction of AP-3 on noncross-linked membranes isolated from PI4KII␣-deficient cells ( Figure 4D , compare lanes 3 and 7, top panels). Concomitantly, AP-3 content increased in the soluble fraction of PI4KII␣ siRNA-treated cells ( Figure 4D , compare lanes 2 and 6, top panels). In contrast, neither the membrane content of AP-1 and coprecipitated clathrin ( Figure 4D , compare lanes 4 and 8, bottom panels) nor the soluble AP-1 content ( Figure  4D , compare lanes 2 and 6, bottom panels), were modified by the decreased levels of PI4KII␣. These results demonstrate that PI4KII␣ stabilizes AP-3 on membranes and sug- (A and B) or HEK293 (C) cells were treated with the cell-permeable cross-linker DSP (even lanes) or DMSO vehicle (odd lanes) and immunoprecipitations using empty beads (A, lanes 3 and 4; B, lanes 3 and 4; C, lanes 5-8), beads decorated with AP-3 ␦ antibodies (A, lanes 7 and 8; B, lanes 5 and 6; C, lanes 9 -12), beads decorated with transferrin receptor antibodies (TrfR. A, lanes 5 and 6), or beads decorated with AP-1 ␥ antibodies (B, lanes 1 and 2). Immunocomplexes were resolved by SDS-PAGE and analyzed by immunoblot using antibodies to PI4KII␣, AP-3 subunits (␦, 3 and ␤3), transferrin receptor (TrfR), clathrin, ZnT3, AP-1 ␥ adaptin, and GFP. PI4KII␣ specifically coprecipitated with AP-3, clathrin, and ZnT3 but not with transferring receptor or AP-1 after DSP cross-linking. HEK293 cells (C) expressing WT or dileucine mutant (L60A L61A) PI4KII␣ tagged with GFP were processed for immunoprecipitation as described. AP-3 coprecipitates WT GFP-PI4KII␣ but does not coprecipitate the dileucine mutant. Input lanes correspond to 10 -15%. 4) and PI4KII␣ siRNA-treated HEK293 cells (lanes 5-8) were treated with the cell-permeable cross-linker DSP (even lanes) or DMSO vehicle (odd lanes) and fractionated into cytosol (lanes 1, 2, 5, and 6) and membrane (lanes 3, 4, 7, and 8) fractions by ultracentrifugation. Cell fractions were dissolved in detergent and immunoprecipitated using beads decorated with AP-3 ␦ antibodies (lanes 1-8, top panels) or beads decorated with AP-1 ␥ antibodies (lanes 1-8, bottom panels). Immunocomplexes were resolved by SDS-PAGE and analyzed by immunoblot using antibodies to PI4KII␣, AP-3 ␦ adaptin (␦), AP-1 ␥ adaptin (␥), and clathrin. PI4KII␣ specifically coprecipitated with AP-3 and clathrin from membrane fractions after DSP cross-linking. PI4KII␣ down-regulation selectively decreases AP-3 content in membranes (compare lanes 4 and 8). Input lanes correspond to 10 -15% of either cytosol (lanes 9 and 10) or membrane (lanes 11 and 12) extracts. N ϭ 2. gest that the adaptor complex AP-1 is regulated by a lipid kinase other than PI4KII␣.
PI4KII␣ Kinase Activity and Sorting Motif Are Required for PI4KII␣ Endosomal Localization
The hypothesis that PI4KII␣ is an enzymatic cargo/regulator of a transport pathway predicts that mutants in its sorting motif or kinase domain should similarly affect PI4KII␣ endosomal distribution, generate similar endosomal phenotypes, and similarly affect PI4KII␣ interaction with AP-3. To explore these predictions, we ablated the PI4KII␣-sorting motif ( 56 ERQPLL 61 in rat or 57 ERQPLL 62 in human) and its kinase activity by site-directed mutagenesis. PI4KII␣ mutants lacking the first 92 amino acids, a domain where the dileucine motif resides, display WT levels of kinase activity when expressed in HEK293 cells (Barylko et al., 2002) . Because the ERQPLL sorting motif and kinase activity reside in independent PI4KII␣ domains, we used this to our advantage.
We first sought to determine if PI4KII␣ enzymatic activity and/or sorting motif would be required to properly localize PI4KII␣ with the adaptor complex AP-3 and endocytic compartments. Human PI4KII␣ tagged with HA as well as mutants in the kinase catalytic aspartate (D308A; Barylko et al., 2002) or its dileucine-sorting motif (L61-62A) were expressed in HEK293 cells and analyzed by immunofluorescence. Transfected cells were double-labeled with antibodies against AP-3 ␦ or AP-1 ␥ adaptins ( Figure 5 ) with one of the following antibodies against: the HA epitope (Figures 5 and 6 ) as well as antigens from either early stages of the endocytic route (TrfR) or late endosome/lysosomes (LAMP-1, Figure 6 ). Half of WT PI4KII␣-HA containing organelles were also positive for AP-3 (Figures 5,A and C, u, 52.6 Ϯ 2.8, n ϭ 13, p Ͻ 0.0001). Importantly, the extent of colocalization between AP-3 and PI4KII␣-HA was significantly reduced to 28 and 36% in PI4KII␣-HA mutants lacking either its sorting motif ( Figure 5 , A and C, L61-62A PI4KII␣-HA) or its kinase activity ( Figure 5 , A and C, D308A PI4KII␣-HA, p ϭ 0.0002), respectively. In contrast, AP-1 colocalized poorly with either endogenous ( Figure 5C , nontransfected, NT, f) or exogenously expressed WT PI4KII␣-HA ( Figure 5B -C, PI4KII␣-HA, u). Furthermore, ablation of the PI4KII␣-HA-sorting motif minimally affected PI4KII␣-HA colocalization with AP-1 ( Figure  5 , B and C, L61-62A PI4KII␣-HA). Curiously, and in stark contrast with AP-3, the colocalization of the kinase-deficient D308A PI4KII␣-HA mutant with AP-1 increased twofold when compared with WT PI4KII␣-HA ( Figure 5 , B and C, D308A PI4KII␣-HA, p Ͻ 0.0001). These results support the hypothesis that PI4KII␣ preferentially associates with AP-3-positive compartments by a mechanism that requires PI4KII␣ enzymatic activity and sorting motif.
The decreased colocalization of mutant forms of PI4KII␣-HA with AP-3 occurred concomitantly with a change of the kinase subcellular localization along the endocytic route. Wild-type PI4KII␣-HA colocalized with LAMP-1 and minimally with TrfR ( Figure 6 ). These findings recapitulate the subcellular distribution of endogenous PI4KII␣ in neuronal and nonneuronal cell types (Salazar et al., 2005 (Salazar et al., , 2006 Minogue et al., 2006) . In contrast, D308A PI4KII␣-HA and L61-62A PI4KII␣-HA displayed identical phenotypes characterized by colocalization with TrfR, yet minimal colocalization with LAMP-1 (Figure 6 ). These results demonstrate that both PI4KII␣ kinase activity and dileucine-based sorting information are required to target the kinase to its proper subcellular localization.
PI4KII␣ Kinase Activity and Sorting Motif Are Required to Rescue PI4KII␣ Loss-of-Function Endocytic Mutant
Phenotypes PI4KII␣ lacking either its kinase activity or its sorting motif display a similarly abnormal subcellular distribution. This observation is consistent with a model wherein PI4KII␣ behaves both as a cargo and a regulator of a transport route. To further test this model, we determined whether kinase activity and the 57 ERQPLL 62 motif are required to rescue PI4KII␣ loss-of-function endosomal mutant phenotypes. The cellular levels of PI4KII␣ were reduced in HEK293 cells using siRNA. Immunofluorescence microscopy was performed to assess hypomorphic phenotypes on AP-3 cargoes Figure 6 . PI4KII␣ kinase activity and sorting motif are required for proper PI4KII␣ localization. Human wild-type (WT), kinase-inactive (D308A), or dileucine mutant (L61-62A) PI4KII␣-HA were expressed in HEK293 cells, and cells were stained with HA antibodies plus either LAMP1 or transferring receptor (TrfR) antibodies. WT PI4KII␣-HA colocalized significantly with LAMP-1 and minimally with TfR, whereas D308A and L61-62A PI4KII␣-HA displayed the opposite pattern, colocalizing significantly with TfR and minimally with LAMP-1. Scale bars, 5 m.
and membrane proteins found in the transition between early and late endosome/lysosomes. Significant reduction of PI4KII␣ by siRNA was observed both by immunoblot (Figures 4A , lane 3, and 9A, lane 2) and immunofluorescence ( Figure 7, A-E) . Immunostaining for the AP-3 cargo LAMP-1 in PI4KII␣ siRNA-treated cells revealed a dramatic impact on LAMP-1-positive organelles. In contrast to control siRNA-treated cells in which LAMP-1 displays punctate localization throughout the cytoplasm ( Figure 7A ), PI4KII␣ siRNA treatment induced a phenotype characterized by 1) the formation of large (1-7 m) circular organelles that contained LAMP-1 and 2) a reduction in the punctate pattern of LAMP-1 seen in control siRNA-treated cells ( Figure  7A ). Quantification of the enlarged organelle phenotype revealed a penetrance of ϳ5% in control siRNA-treated cells. In contrast, ϳ50% of PI4KII␣ siRNA-treated cells displayed this phenotype (44.5 Ϯ 8.1%, n ϭ 3, Figure 8 ). We analyzed whether membrane proteins that reside in the interface between early and late endosomes were also accumulated on similar large circular organelles in PI4KII␣ siRNA-treated cells. We focused on syntaxin 8 and Vti1b, Q-t-SNAREs involved in fusion steps between early and late endosomes (Mullock et al., 2000; Ward et al., 2000; Bogdanovic et al., 2002; Pryor et al., 2004) . Much like LAMP-1, these SNAREs accumulated in enlarged endosomes. Furthermore, there was a reduction of puncta positive for Vti1b and syntaxin 8 in the cytoplasm in PI4KII␣ siRNA-treated cells (Figure 7 , B and C). TrfR and to a much lesser extent EEA1 were also observed on enlarged endosomal compartments yet without altering TrfR or EEA1-positive puncta in the cytoplasm (Figure 7, D and E) . Enlarged organelles were negative for TGN46, a marker for the trans-Golgi network (data not shown). Together these results suggest that down-regulation of PI4KII␣ results in mis-targeting of an AP-3 cargo (LAMP-1) and alters the distribution of Q-t-SNARES (syntaxin 8 and Vti1b) involved in early to late endosomal fusion events.
We utilized the PI4KII␣ siRNA-induced LAMP-1 enlarged organelle phenotype to test whether PI4KII␣ kinase activity and its sorting motif were required to rescue this phenotype (Figure 8 ). For this purpose, we used a sequential protocol of PI4KII␣ siRNA followed by re-expression of WT and mutant versions of human HA-tagged PI4KII␣ driven from a CMV promoter. This allowed us to express HA-PI4KII␣ without the need to create siRNA-resistant PI4KII␣ constructs (see Figure 9 ). Reexpression of WT PI4KII␣-HA reduced the penetrance of the enlarged endosome phenotype from 44.5 Ϯ 8.1% (n ϭ 3, Figure 8 ) to 24.7 Ϯ 2% (n ϭ 3, Figure 8 ). This partial rescue may be related to the expression levels of HA-PI4KII␣, because overexpression of the kinase also induced enlarged endosomal vesicles (Balla et al., 2002) . In contrast, re-expression of the kinase-inactive D308A PI4KII␣-HA (49.5 Ϯ 2.5%, n ϭ 3, Figure 8 ) or the L61-62A PI4KII␣-HA mutant lacking its sorting motif (60.1 Ϯ 4%, n ϭ 3, Figure 8 ) failed to rescue the enlarged endosome phenotype, indicating a requirement for both PI4KII␣ kinase activity and the dileucine-sorting motif for proper PI4KII␣ function. The phenotypic similarities between PI4KII␣ mutants lacking kinase activity or AP-3-sorting information in their colocalization with AP-3, their subcellular localization, as well as their inability to rescue PI4KII␣ loss-of-function could be ascribed to a similar failure of both PI4KII␣ mutants to form complexes with AP-3 on membranes. We explored this hypothesis by performing cross-linking and AP-3 immunoprecipitations using HEK293 cells expressing either WT kinase, kinase-inactive D308A, or the dileucine mutants L61A or L61-62A PI4KII␣-HA (Figure 9 ). To exclude the contribution of endogenous PI4KII␣, similar experiments were performed in which the levels of endogenous PI4KII␣ were reduced using siRNA. In each case, comparable results were obtained ( Figure 9, A and B) . PI4KII␣ siRNA effectively and selectively abrogated the expression of PI4KII␣ ( Figure 9A, compare lanes 1 and 2) . We used PI4KII␣ siRNA-treated cells and rescued with PI4KII␣-HA as a reference ( Figure 9A, lanes 3, 11, and 12 ) to assess the consequences of mutations either in the dileucinesorting motif (Figure 9A, lanes 4, 5, (13) (14) (15) (16) or the kinase domain ( Figure 9A, lanes 6, 17, and 18 ). Wild-type or mutant PI4KII␣-HA were expressed to levels similar to those found in control siRNA-treated cells ( Figure 9A , compare lanes 1 and 3-6). As previously described ( Figure 3C ) mutants lacking either one or two leucines of the 57 ERQPLL 62 -sorting motif ( Figure 9A , lanes 13-16) failed to interact with AP-3. In fact, only ϳ25% of dileucine mutant PI4KII␣-HA formed a cross-linkable complex with AP-3 in non-siRNA-treated HEK293 cells ( Figure 9B , dark gray bars, n ϭ 3). Similarly, only ϳ10% of the dileucine mutant PI4KII␣-HA formed a cross-linkable complex with AP-3 in PI4KII␣-siRNA-treated cells ( Figure 9B , light gray bars, n ϭ 1). The D308A PI4KII␣-HA mutant lacking kinase activity formed a crosslinkable complex with AP-3, with half of the efficiency displayed by WT PI4KII␣-HA ( Figure 9A, lanes 17 and 18) . The association of D308A PI4KII␣-HA with AP-3 was identical whether cross-linking and AP-3 immunoprecipitations were performed in nontreated (54.1 Ϯ 2.1%, n ϭ 3, Figure 9B ) or PI4KII␣-siRNA-treated cells (56%, n ϭ 1, Figure 9 , A and B). These results indicate that PI4KII␣ kinase activity and the dileucine-sorting motif facilitate PI4KII␣ interaction with AP-3 on membranes. Moreover, the decreased interaction of PI4KII␣ mutants with AP-3 correlates with the inability of these mutants to rescue PI4KII␣ hypomorph endosome phenotypes. Because the ablation of the PI4KII␣ dileucine motif produces more pronounced phenotypes that those observed in kinase deficient PI4KII␣, these results suggest that the dileucine motif acts upstream of the kinase activity in facilitating adaptor recruitment.
DISCUSSION
Here we demonstrate a selective interaction between the adaptor complex AP-3 and the membrane-anchored lipid kinase PI4KII␣. This interaction requires a dileucine motif present in PI4KII␣, which is necessary for the proper endosomal targeting of this protein. The PI4KII␣ sorting sequence (ERQPLL) is identical to the motif found in tyrosinase, a membrane protein targeted from endosomes to melanosomes by virtue of its binding to AP-3 (Honing et al., 1998; Blagoveshchenskaya et al., 1999; Theos et al., 2005) . Our data support the hypothesis that PI4KII␣ is an AP-3 cargo protein. Consistent with this model are the observations that PI4KII␣ is enriched in AP-3-containing vesicles and that AP-3 is required to properly localize PI4KII␣ both in neuronal and nonneuronal cells (Salazar et al., 2005 (Salazar et al., , 2006 . In addition, our work demonstrates a requirement for PI4KII␣ kinase activity in regulating the delivery of AP-3-dependent cargoes to lysosomal compartments. PI4KII␣ mutants that selectively abrogate its kinase activity or its sorting information display similar endosomal mutant phenotypes, comparably impair their capacity to rescue PI4KII␣ loss-of-function phenotypes and alter PI4KII␣ binding to AP-3 either completely or partially. These data support a model whereby PI4KII␣ possesses two domains required for localization to late endosomal-lysosomal compartments via an AP-3-dependent mechanism.
PI4KII␣ acts as a cargo that encodes in its primary sequence a catalytic activity capable of regulating its own sorting mechanism. This behavior seems unique among enzymatic activities regulating adaptor function such as GTPases (Bonifacino and Glick, 2004) , chaperones (Sousa and Lafer, 2006) , protein kinases (Conner and Schmid, 2003) , lipid kinases (Di Paolo and De Camilli, 2006) , and lipid phosphatases (Di Paolo and De Camilli, 2006) . In contrast with PI4KII␣, these regulatory components are recruited from cytosol to membranes at different stages of vesicle biogenesis through interactions with adaptors or other vesicle biogenesis components. For example, phosphatidylinositol 4-kinase type III␤ and phosphatidylinositol kinase type I ␥ are recruited to membranes by activation of GTPases and/or interactions with the adaptors (Godi et al., 1999; Krauss et al., 2003; Di Paolo et al., 2004; Bairstow et al., 2006; Nakano-Kobayashi et al., 2007) . Importantly, these enzymes do not become enriched in the vesicles that they help to assemble (Blondeau et al., 2004; Borner et al., 2006; Takamori et al., 2006) .
Phosphatidylinositol kinase type I ␥ exemplifies a regulatory sorting mechanism through interactions with the adaptor complexes AP-2 and -1 (Ling et al., 2007) . Phosphatidyl- inositol kinase type I ␥ associates with AP-1 via a YXX⌽ motif present in this kinase. However, the membrane protein whose sorting is regulated by phosphatidylinositol kinase type I ␥ and AP-1 is E-cadherin. This cell adhesion protein is sorted because it binds phosphatidylinositol kinase type I ␥ rather than AP-1 (Ling et al., 2007) . Thus, type I ␥ kinase has been proposed to act as a scaffold bridging AP-1 and E-cadherin (Ling et al., 2007) . In contrast, our data demonstrate a novel mechanism in which a cargo encodes a self-contained regulatory enzymatic function. However, the PI4KII␣-AP-3 interaction does not preclude that PI4KII␣ could act as a scaffold for other cargo and/or regulatory proteins.
PI4KII␣ possesses two reported subcellular localizations. In two reports PI4KII␣ was observed in the Golgi complex (Wang et al., 2003 (Wang et al., , 2007 . In other studies, PI4KII␣ was found to preferentially localize to endocytic compartments or postendocytic vesicles (Balla et al., 2002; Guo et al., 2003; Salazar et al., 2005 Salazar et al., , 2006 Balla and Balla, 2006; Minogue et al., 2006; Takamori et al., 2006; Xu et al., 2006) , and only minimal PI4KII␣ colocalized with Golgi markers or the adaptor complex AP-1 (Balla et al., 2002; Salazar et al., 2005 Salazar et al., , 2006 . Similarly, here we demonstrate that PI4KII␣ is present on the limiting membranes of Rab5Q79L-enlarged rat neuroendocrine endosomes where it colocalizes with AP-3 and the AP-3-interacting molecules clathrin (Dell'Angelica et al., 1998) , ZnT3 (Salazar et al., 2004) , and VAMP7-TI (MartinezArca et al., 2003) but not with AP-1. PI4KII␣ endosomal localization is further supported by: 1) PI4KII␣ down-regulation selectively affects recruitment of an endosomal adaptor, AP-3 Peden et al., 2004) , to membranes without altering the subcellular distribution of the Golgi localized AP-1 adaptor complex (Bonifacino and Traub, 2003; Robinson, 2004) . 2) PI4KII␣ mutants lacking dileucine sorting information accumulate in TrfR-positive endosomes and 3) PI4KII␣ siRNA-induced engorged organelles abnormally accumulate LAMP-1, a well-established AP-3 cargo. Similarly, enlarged organelles containing TrfR or the SNAREs syntaxin 8 or Vti1b can be found in PI4KII␣ siRNA-treated cells. However, enlarged endosomes lack detectable levels of the trans-Golgi network marker TGN46, suggesting that these abnormal organelles are unlikely to result from a fusion of endosomes and the trans-Golgi network. These findings do not preclude that some PI4KII␣ may be present in the Golgi complex (Wang et al., 2003 (Wang et al., , 2007 .
Enlarged endosomes induced by PI4KII␣ knockdown could result from enhanced accruement of membrane components due to defective PI4KII␣-dependent vesicle formation. These vesicles could participate in forward transport between early and late stages of the endocytic route. Alternatively, vesicles formed by a PI4KII␣-dependent mechanism could participate in endosome maturation (Rink et al., 2005) by retrieval of components. Vesicles formed by a PI4KII␣-dependent process could deliver SNAREs, among other membrane proteins, either in forward or retrograde (retrieval) transport processes. This hypothesis is attractive because AP-3 deficiency (Salazar et al., 2006) , defects in the BLOC-1 complex that interacts with AP-3 (Di Pietro et al., 2006; Salazar et al., 2006) , and PI4KII␣ deficiency (data Figure 9 . PI4KII␣ kinase activity and dileucine-sorting motif are required to interact with AP-3. (A) HEK293 cells were treated with control siRNA (lanes 1, 7, and 8) or with PI4KII␣ siRNA (lanes 2-6 and 9 -18). siRNAtreated cells were transfected with PI4KII␣-HA WT (lanes 3, 11, and 12) or PI4KII␣-HA carrying mutations in its sorting motif (L61A, lanes 4, 13, and 14; L61-62A, lanes 5, 15, and 16) or kinase active site (D308A, lanes 6, 17, and 18). Cells were treated with the cell-permeable cross-linker DSP (even lanes) or DMSO vehicle (odd lanes), and cross-linked complexes were immunoprecipitated using beads decorated with AP-3 ␦ SA-4 antibodies. Immunocomplexes were resolved by SDS-PAGE and analyzed by immunoblot using antibodies to PI4KII␣, AP-3 subunits (␦ and 3) and transferrin receptor (TrfR). Inputs (lanes 1-6) correspond to a 10%. (B) Light gray bars, the quantification of the experiment depicted in A. Dark gray bars, the average of three independent experiments identical to A except that HEK293 cells were not siRNA treated. Note that all quantifications were normalized to the expression level of the recombinant PI4KII␣ (input lanes). p values" *1 and *3 Ͻ 0.0001, *2 Ͻ 0.003.
shown here) perturb the subcellular localization or cellular levels of endosomal SNARE proteins. Moreover, syntaxin 8 and Vti1b, two SNAREs found in the PI4KII␣-knockdowninduced enlarged endosomes, form a SNARE fusogenic complex with VAMP-7-TI (Mullock et al., 2000; Ward et al., 2000; Bogdanovic et al., 2002; Pryor et al., 2004) , a SNARE that binds to and is targeted by AP-3 (Martinez-Arca et al., 2003; Salazar et al., 2006) .
We utilized the high transfection and siRNA efficiency of HEK293 cells to demonstrate that knockdown of PI4KII␣ levels by siRNA results in aberrant morphology of compartments of the endosomal system and abnormal accumulation of LAMP1 or TrfR in enlarged structures. This phenotype could be partially rescued by transiently transfecting PI4KII␣ after knockdown of the endogenous PI4KII␣. In contrast, PI4KII␣ either lacking its kinase activity or its ERQPLL dileucine motif failed to rescue the phenotype, indicating a binary requirement in restoring the targeting of LAMP-1 and the morphology of these endocytic organelles. Despite the fact that PI4KII␣ mutants lacking either their ERQPLL motif or kinase activity display endocytic phenotypes of similar magnitude and penetrance , these two mutants differ in the extent to which they bind to AP-3 ( Figure 9 ). PI4KII␣ lacking a dileucine motif abrogates AP-3 binding by 80 -90%. In contrast, PI4KII␣ lacking kinase activity binds AP-3 with half efficiency. These findings confirm that the kinase activity is in part required to recruit AP-3 to membranes and suggest that the dileucine motif acts upstream of the kinase activity in facilitating adaptor recruitment. We propose a model in which initial interactions between AP-3 and the PI4KII␣ dileucine motif result in concentration of PI4KII␣ in microdomains on the limiting membrane of endosomes. This concentrated "patch" of PI4KII␣ would then result in a localized patch of kinase activity, resulting in a microdomain enriched in PtdIns(4)P. PtdIns(4)P-enriched microdomains could function in a positive feedback loop to recruit additional AP-3 complexes and/or other machineries involved in either the formation and/or the targeting of AP-3 vesicles. Without kinase activity and the production of a PtdIns(4)P-enriched microdomain, PI4KII␣ would transiently interact with AP-3 via the dileucine motif, but fail to recruit the additional AP-3 complexes and/or additional components required to form and/or target vesicles. Our work and this model suggest a novel mechanism in which adaptors utilize canonical sorting motifs to recruit membrane-anchored enzymes that regulate adaptor function.
